Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Mycel

Mycelium powered platform that bridges bio-tech, advanced material science with next generation materials cultivated by mycelium from Korea
2020
Nov-50
11-50
Gunpo, Kyonggi-do, South Korea
No tags found for this post.

Innovation

Industry Problem

Petroleum- and animal-derived materials create toxicity, waste and end-of-life challenges across consumer and industrial products.

R&D Focus

Mycelium biomaterials, biofabrication, circular materials and biomass regeneration.

Innovative Solution

Cultivates mycelium into formed, biodegradable materials and converts residual biomass into regenerative inputs for soil and cosmetic uses.

Solution Effectiveness

The company describes its material system as 100% bio-based, 100% biodegradable and zero-waste; these are company claims.

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

19.41M

Last Funding Amount

18.58M

Last Funding Date

15-07-2022

Startup Stage

Early Stage

Lead Investors

Stone Bridge Ventures, Hyundai Motor Group, Kia Motors, Industrial Bank of Korea, GS Ventures

About

MYCEL, a spin-off startup from Hyundai & KIA Motor Group, is a South Korea-based mycelium powered platform that bridges bio-tech, advanced material science with next generation materials cultivated by mycelium through a fully controlled fermentation.

Products

Product

LSSC MAT, CELMURE and PCLM mycelium-based material systems.

Star Product

LSSC MAT – the company’s pure-mycelium base material platform.

Demo Product or Complete Product?

B2B material platform with named product families and customer-driven development; food-protein commercialization was not evident.

Future Plan

Market Expansion

Targets scalable industrial material applications rather than primarily food protein.

Something missing or incorrect on this page? Help us enrich this information